[ad_1]
(HealthDay) – The drug artesunate – the first-line treatment for severe malaria recommended by the World Health Organization – will become the first-line treatment for severe malaria in the United States, says the Center. American disease control and prevention to health care providers.
The new directive marks a change in the US treatment protocol that became necessary after the manufacturer of the IV drug, approved by the US Food and Drug Administration, was arrested by the US the manufacturer.
At present, artesunate is not approved by the FDA or commercially available in the United States. The CDC will therefore use a special regulatory measure from the FDA to ensure the availability of IV artesunate for the treatment of severe malaria.
As of April 1, health care providers must call the CDC Malaria Assistance Line (1-770-488-7788) to obtain IV artesunate. After a CDC expert has confirmed that artesunate IV is required, the drug will be distributed free of charge to the CDC quarantine center closest to the requesting hospital and a hospital representative. can pick him up at the center. The CDC stores artesunate in 10 quarantine stations and will collaborate with stations and hospitals to ensure prompt delivery of the drug. According to the CDC, there will be a sufficient amount of IV artesunate for the treatment of all cases of severe malaria in the United States.
The drug combination of malaria with hemolytic anemia is not clear
More information
Copyright © 2016 HealthDay. All rights reserved.
Quote:
Guidelines list new first-line treatment for severe malaria in the United States (March 29, 2019)
recovered on March 29, 2019
from https://medicalxpress.com/news/2019-03-guidance-first-line-treatment-severe-malaria.html
This document is subject to copyright. Apart from any fair use for study or private research purposes, no
part may be reproduced without written permission. Content is provided for information only.
[ad_2]
Source link
